Home / HLTRF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does HLTRF make money? Does HLTRF have pricing power? What's the Earnings Whisper? Will HLTRF profit more as the business scales? What is HLTRF's management track record? Is HLTRF's current price justified?

HLS Therapeutics Inc.

$2.82 -$0.61 (-17.78%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$2.64

Day Range

$2.82 - $2.82

Year Range

$2.64$4.02

Market Cap

88.2M

AVG Volume

486

Trailing/Forward PE

-10.61/-

PEG ratio

0.16

Dividend Yield

Next Earnings Date

2026-11-12

Primary Exchange

Other OTC

Revenue (USD) · TTM

HLTRF Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
26 Q2	56.3M
26 Q1	55.8M
25 Q4	55.73M
25 Q3	55.85M
25 Q2	56.42M
25 Q1	56.77M
24 Q4	56.56M
24 Q3	57.32M
24 Q2	59.27M
24 Q1	61.17M

Net Income (USD) · TTM

HLTRF Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-8.56M
26 Q1	-10.28M
25 Q4	-12.45M
25 Q3	-14.12M
25 Q2	-15.04M
25 Q1	-17.98M
24 Q4	-19.63M
24 Q3	-22.15M
24 Q2	-24.21M
24 Q1	-27.97M

Operating Income (USD) · TTM

HLTRF Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-4.47M
26 Q1	-4.1M
25 Q4	-4.1M
25 Q3	-7.38M
25 Q2	-11.03M
25 Q1	-6.42M
24 Q4	-7.69M
24 Q3	-5.78M
24 Q2	-3.72M
24 Q1	-10.53M

EBITDA (USD) · TTM

HLTRF EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	18.35M
26 Q1	17.8M
25 Q4	17.44M
25 Q3	16.45M
25 Q2	15.49M
25 Q1	17.73M
24 Q4	17.21M
24 Q3	16.35M
24 Q2	16.36M
24 Q1	10.49M

Cash Flows (USD) · TTM

HLTRF Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	17.73M
26 Q1	18.4M
25 Q4	15.65M
25 Q3	12.43M
25 Q2	11.73M
25 Q1	10.73M
24 Q4	7.45M
24 Q3	8.07M
24 Q2	11.9M
24 Q1	12.02M

EPS (USD) · TTM

HLTRF EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-0.27
26 Q1	-0.32
25 Q4	-0.39
25 Q3	-0.44
25 Q2	-0.47
25 Q1	-0.56
24 Q4	-0.61
24 Q3	-0.69
24 Q2	-0.75
24 Q1	-0.86

Expenses (USD) · TTM

HLTRF Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	22.25M
26 Q1	23.13M
25 Q4	23.42M
25 Q3	24.36M
25 Q2	25.32M
25 Q1	25.6M
24 Q4	26.94M
24 Q3	26.76M
24 Q2	29.03M
24 Q1	31.36M

Shares Outstanding (USD) · TTM

HLTRF Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
26 Q2	-426.17K
26 Q1	218.83K
25 Q4	-114.17K
25 Q3	-527.29K
25 Q2	-1.04M
25 Q1	-1.51M
24 Q4	-1.01M
24 Q3	587.03K
24 Q2	1.72M
24 Q1	1.88M

Dividends (USD)

HLTRF Dividends (USD) by quarter
Period	Dividends (USD)
Apr 23	0.04
Jan 23	0.04
Oct 22	0.04
Jul 22	0.04
Apr 22	0.04
Jan 22	0.04
Oct 21	0.04
Jul 21	0.04
Apr 21	0.04
Jan 21	0.04

Free Cash Flow Yield

HLTRF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	20.87%
Sep 26	22.29%
Aug 26	21.32%
Aug 26	21.4%
Aug 26	21.17%
Aug 26	19.75%
Jul 26	19.75%
Jul 26	19.61%
Jul 26	19.04%
Jul 26	19.04%
Jul 26	19.61%
Jun 26	15.83%
Jun 26	15.83%
Jun 26	15.88%
Jun 26	15.88%
May 26	15.35%
May 26	15.35%
May 26	14.63%
May 26	14.63%
May 26	14.54%
Apr 26	14.71%
Apr 26	14.8%
Apr 26	15.59%
Apr 26	16.68%
Mar 26	13.19%
Mar 26	11.78%
Mar 26	11.78%
Mar 26	11.78%
Feb 26	11.78%
Feb 26	11.78%
Feb 26	11.78%
Feb 26	11.78%
Jan 26	11.78%
Jan 26	11.78%
Jan 26	11.78%
Jan 26	11.78%
Jan 26	11.54%
Dec 25	10.78%
Dec 25	10.84%
Dec 25	10.84%
Dec 25	10.69%
Nov 25	10.69%
Nov 25	10.69%
Nov 25	10.69%
Nov 25	9.22%
Oct 25	9.22%
Oct 25	9.22%
Oct 25	9.22%
Oct 25	9.22%
Oct 25	9.76%
Sep 25	8.88%
Sep 25	8.82%
Sep 25	8.82%
Sep 25	8.88%
Aug 25	8.88%
Aug 25	8.88%
Aug 25	9%
Aug 25	9.15%
Aug 25	9.12%
Jul 25	9.46%
Jul 25	9.1%
Jul 25	9.1%
Jul 25	9.22%
Jun 25	6.41%
Jun 25	6.41%
Jun 25	6.41%
Jun 25	6.41%
May 25	7.28%
May 25	7.28%
May 25	7.28%
May 25	7.28%
May 25	6.82%
Apr 25	7.82%
Apr 25	7.92%
Apr 25	7.92%
Apr 25	7.13%
Mar 25	7.81%
Mar 25	7.76%
Mar 25	9.3%
Mar 25	8.73%
Feb 25	8.61%
Feb 25	8.61%
Feb 25	9.3%
Feb 25	9.3%
Jan 25	9%
Jan 25	9%
Jan 25	9.77%
Jan 25	9.23%
Jan 25	9.23%
Dec 24	13.89%
Dec 24	14.77%
Dec 24	15.57%
Dec 24	15.84%
Nov 24	14.38%
Nov 24	15.38%
Nov 24	15.7%
Nov 24	13.69%
Nov 24	14.95%
Oct 24	15.77%
Oct 24	13.16%

Price to Sales

HLTRF Price to Sales by quarter
Period	Price to Sales
Sep 26	1.58
Sep 26	1.48
Aug 26	1.55
Aug 26	1.54
Aug 26	1.56
Aug 26	1.67
Jul 26	1.67
Jul 26	1.68
Jul 26	1.73
Jul 26	1.73
Jul 26	1.68
Jun 26	1.77
Jun 26	1.77
Jun 26	1.77
Jun 26	1.77
May 26	1.83
May 26	1.83
May 26	1.92
May 26	1.92
May 26	1.93
Apr 26	1.91
Apr 26	1.9
Apr 26	1.8
Apr 26	1.68
Mar 26	1.69
Mar 26	1.89
Mar 26	1.89
Mar 26	1.89
Feb 26	1.89
Feb 26	1.89
Feb 26	1.89
Feb 26	1.89
Jan 26	1.89
Jan 26	1.89
Jan 26	1.89
Jan 26	1.89
Jan 26	1.93
Dec 25	1.93
Dec 25	1.92
Dec 25	1.92
Dec 25	1.95
Nov 25	1.95
Nov 25	1.95
Nov 25	1.95
Nov 25	2.25
Oct 25	2.25
Oct 25	2.25
Oct 25	2.25
Oct 25	2.25
Oct 25	2.13
Sep 25	2.13
Sep 25	2.15
Sep 25	2.15
Sep 25	2.13
Aug 25	2.13
Aug 25	2.13
Aug 25	2.1
Aug 25	2.07
Aug 25	2.07
Jul 25	2
Jul 25	2.08
Jul 25	2.08
Jul 25	2.05
Jun 25	2.06
Jun 25	2.06
Jun 25	2.06
Jun 25	2.06
May 25	1.81
May 25	1.81
May 25	1.81
May 25	1.81
May 25	1.93
Apr 25	1.69
Apr 25	1.66
Apr 25	1.66
Apr 25	1.85
Mar 25	1.8
Mar 25	1.81
Mar 25	1.51
Mar 25	1.61
Feb 25	1.64
Feb 25	1.64
Feb 25	1.51
Feb 25	1.51
Jan 25	1.56
Jan 25	1.56
Jan 25	1.44
Jan 25	1.53
Jan 25	1.53
Dec 24	1.44
Dec 24	1.36
Dec 24	1.29
Dec 24	1.27
Nov 24	1.4
Nov 24	1.31
Nov 24	1.28
Nov 24	1.47
Nov 24	1.34
Oct 24	1.27
Oct 24	1.53

EV/EBITDA

HLTRF EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	6.74
Sep 26	6.42
Aug 26	6.63
Aug 26	6.61
Aug 26	6.67
Aug 26	7.02
Jul 26	7.02
Jul 26	7.05
Jul 26	7.21
Jul 26	7.21
Jul 26	7.05
Jun 26	7.85
Jun 26	7.85
Jun 26	7.83
Jun 26	7.83
May 26	8.02
May 26	8.02
May 26	8.31
May 26	8.31
May 26	8.35
Apr 26	8.28
Apr 26	8.24
Apr 26	7.93
Apr 26	7.56
Mar 26	8.36
Mar 26	9.05
Mar 26	9.05
Mar 26	9.05
Feb 26	9.05
Feb 26	9.05
Feb 26	9.05
Feb 26	9.05
Jan 26	9.05
Jan 26	9.05
Jan 26	9.05
Jan 26	9.05
Jan 26	9.18
Dec 25	9.83
Dec 25	9.79
Dec 25	9.79
Dec 25	9.89
Nov 25	9.89
Nov 25	9.89
Nov 25	9.89
Nov 25	11.02
Oct 25	11.02
Oct 25	11.02
Oct 25	11.02
Oct 25	11.02
Oct 25	10.57
Sep 25	9.41
Sep 25	9.46
Sep 25	9.46
Sep 25	9.41
Aug 25	9.41
Aug 25	9.41
Aug 25	9.32
Aug 25	9.21
Aug 25	9.23
Jul 25	9
Jul 25	9.25
Jul 25	9.25
Jul 25	9.16
Jun 25	9.61
Jun 25	9.61
Jun 25	9.61
Jun 25	9.61
May 25	8.8
May 25	8.8
May 25	8.8
May 25	8.8
May 25	9.2
Apr 25	8.39
Apr 25	8.32
Apr 25	8.32
Apr 25	8.93
Mar 25	9.44
Mar 25	9.48
Mar 25	8.43
Mar 25	8.78
Feb 25	8.86
Feb 25	8.86
Feb 25	8.43
Feb 25	8.43
Jan 25	8.61
Jan 25	8.61
Jan 25	8.18
Jan 25	8.47
Jan 25	8.47
Dec 24	8.32
Dec 24	8.01
Dec 24	7.76
Dec 24	7.68
Nov 24	8.15
Nov 24	7.82
Nov 24	7.72
Nov 24	8.4
Nov 24	7.95
Oct 24	7.7
Oct 24	8.62

Price/Operating Cashflow

HLTRF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	4.45
Sep 26	4.17
Aug 26	4.36
Aug 26	4.34
Aug 26	4.39
Aug 26	4.71
Jul 26	4.71
Jul 26	4.74
Jul 26	4.88
Jul 26	4.88
Jul 26	4.74
Jun 26	5.79
Jun 26	5.79
Jun 26	5.77
Jun 26	5.77
May 26	5.97
May 26	5.97
May 26	6.27
May 26	6.27
May 26	6.3
Apr 26	6.23
Apr 26	6.19
Apr 26	5.88
Apr 26	5.5
Mar 26	6.81
Mar 26	7.63
Mar 26	7.63
Mar 26	7.63
Feb 26	7.63
Feb 26	7.63
Feb 26	7.63
Feb 26	7.63
Jan 26	7.63
Jan 26	7.63
Jan 26	7.63
Jan 26	7.63
Jan 26	7.79
Dec 25	8.47
Dec 25	8.42
Dec 25	8.42
Dec 25	8.54
Nov 25	8.54
Nov 25	8.54
Nov 25	8.54
Nov 25	9.9
Oct 25	9.9
Oct 25	9.9
Oct 25	9.9
Oct 25	9.9
Oct 25	9.35
Sep 25	11.22
Sep 25	11.31
Sep 25	11.31
Sep 25	11.22
Aug 25	11.22
Aug 25	11.22
Aug 25	11.07
Aug 25	10.89
Aug 25	10.92
Jul 25	10.54
Jul 25	10.95
Jul 25	10.95
Jul 25	10.81
Jun 25	15.58
Jun 25	15.58
Jun 25	15.58
Jun 25	15.58
May 25	13.71
May 25	13.71
May 25	13.71
May 25	13.71
May 25	14.64
Apr 25	12.77
Apr 25	12.6
Apr 25	12.6
Apr 25	14
Mar 25	12.77
Mar 25	12.85
Mar 25	10.73
Mar 25	11.44
Feb 25	11.59
Feb 25	11.59
Feb 25	10.73
Feb 25	10.73
Jan 25	11.08
Jan 25	11.08
Jan 25	10.22
Jan 25	10.81
Jan 25	10.81
Dec 24	7.16
Dec 24	6.74
Dec 24	6.39
Dec 24	6.28
Nov 24	6.92
Nov 24	6.47
Nov 24	6.34
Nov 24	7.27
Nov 24	6.66
Oct 24	6.31
Oct 24	7.56

Price to Book

HLTRF Price to Book by quarter
Period	Price to Book
Sep 26	1.5
Sep 26	1.41
Aug 26	1.47
Aug 26	1.46
Aug 26	1.48
Aug 26	1.59
Jul 26	1.59
Jul 26	1.6
Jul 26	1.64
Jul 26	1.64
Jul 26	1.6
Jun 26	1.61
Jun 26	1.61
Jun 26	1.6
Jun 26	1.6
May 26	1.66
May 26	1.66
May 26	1.74
May 26	1.74
May 26	1.75
Apr 26	1.73
Apr 26	1.72
Apr 26	1.63
Apr 26	1.52
Mar 26	1.53
Mar 26	1.71
Mar 26	1.71
Mar 26	1.71
Feb 26	1.71
Feb 26	1.71
Feb 26	1.71
Feb 26	1.71
Jan 26	1.71
Jan 26	1.71
Jan 26	1.71
Jan 26	1.71
Jan 26	1.74
Dec 25	1.64
Dec 25	1.63
Dec 25	1.63
Dec 25	1.65
Nov 25	1.65
Nov 25	1.65
Nov 25	1.65
Nov 25	1.91
Oct 25	1.91
Oct 25	1.91
Oct 25	1.91
Oct 25	1.91
Oct 25	1.81
Sep 25	1.81
Sep 25	1.82
Sep 25	1.82
Sep 25	1.81
Aug 25	1.81
Aug 25	1.81
Aug 25	1.78
Aug 25	1.76
Aug 25	1.76
Jul 25	1.7
Jul 25	1.77
Jul 25	1.77
Jul 25	1.74
Jun 25	1.63
Jun 25	1.63
Jun 25	1.63
Jun 25	1.63
May 25	1.43
May 25	1.43
May 25	1.43
May 25	1.43
May 25	1.53
Apr 25	1.34
Apr 25	1.32
Apr 25	1.32
Apr 25	1.47
Mar 25	1.3
Mar 25	1.31
Mar 25	1.09
Mar 25	1.17
Feb 25	1.18
Feb 25	1.18
Feb 25	1.09
Feb 25	1.09
Jan 25	1.13
Jan 25	1.13
Jan 25	1.04
Jan 25	1.1
Jan 25	1.1
Dec 24	1.04
Dec 24	0.97
Dec 24	0.92
Dec 24	0.91
Nov 24	1
Nov 24	0.94
Nov 24	0.92
Nov 24	1.05
Nov 24	0.96
Oct 24	0.91
Oct 24	1.09

No video analysis for this stock yet. Request one from our team.

News: HLTRF

marketbeat.com · 12 Aug 2026

HLS Therapeutics Q2 Earnings Call Highlights

HLS Therapeutics TSE: HLS reported second-quarter fiscal 2026 revenue growth as its cardiovascular portfolio expanded 25% year over year, led by continued gains for Vascepa and the first full quarter of sales for newly launched NILEMDO.

AI Analysis

HLS Therapeutics Inc.

Video analysis: HLTRF

News: HLTRF

HLS Therapeutics Q2 Earnings Call Highlights

Similar companies